510(k) K013272
K013272 is an FDA 510(k) premarket notification submitted by Bayer Corp. for the device "ACS: 180 AND ADVIA CENTAUR THEOPHYLLINE 2 ASSAY". The FDA issued a decision of Substantially Equivalent on October 25, 2001. The device falls under product code KLS (Enzyme Immunoassay, Theophylline), a Class II device regulated under 21 CFR 862.3880. Bayer Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 25, 2001
- Date Received
- October 1, 2001
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Immunoassay, Theophylline
- Device Class
- Class II
- Regulation Number
- 862.3880
- Review Panel
- TX
- Submission Type